WebApr 14, 2024 · Chinook Therapeutics, Inc. (NASDAQ:KDNY – Get Rating) has been assigned a consensus rating of “Buy” from the nine research firms that are presently … Web1 day ago · SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...
8-K: CHINOOK THERAPEUTICS, INC. - MarketWatch
WebApr 14, 2024 · Chinook Therapeutics, Inc. ( NASDAQ:KDNY – Get Rating )’s share price was up 3.2% on Wednesday . The stock traded as high as $21.08 and last traded at $21.04. Approximately 109,125 shares were traded during trading, a decline of 80% from the average daily volume of 540,593 shares. The stock had previously closed at $20.38. WebCHK-336 is a first-in-class, liver-targeted, oral small molecule LDHA inhibitor being developed for the treatment of primary and idiopathic hyperoxaluria. CHK-336 is a novel, potent and selective small molecule lactate dehydrogenase A (LDHA) inhibitor with the potential for once-daily oral dosing. CHK-336 has an engineered liver-targeted tissue ... regards software
Press Release Chinook Therapeutics
WebFeb 22, 2024 · Chinook Therapeutics. Address Seattle, WA. 98109 USA. Industry. Government. Report Job. Report Job. Select a reason for reporting this job. This job is offensive or discriminatory This job appears to be fake This job or the information included is inaccurate This job is an advertisement for something other than hiring ... Web1 day ago · SEATTLE, April 13, Apr 13, 2024 (GLOBE NEWSWIRE via COMTEX) -- SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the ... WebMar 18, 2024 · Get the details of Charles Odeyemi's business profile including email address, phone number, work history and more. Free Tools ; Leads by Industry ; Top … regards spanish translation